Avidian Wealth Enterprises LLC Sells 102 Shares of CME Group Inc. $CME

Avidian Wealth Enterprises LLC cut its stake in shares of CME Group Inc. (NASDAQ:CME) by 5.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,823 shares of the financial services provider’s stock after selling 102 shares during the period. Avidian Wealth Enterprises LLC’s holdings in CME Group were worth $503,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Catalyst Capital Advisors LLC grew its stake in shares of CME Group by 256.9% during the first quarter. Catalyst Capital Advisors LLC now owns 3,662 shares of the financial services provider’s stock worth $971,000 after purchasing an additional 2,636 shares during the period. OMNI 360 Wealth Inc. acquired a new stake in shares of CME Group during the first quarter worth $367,000. Fulcrum Equity Management acquired a new stake in shares of CME Group during the first quarter worth $258,000. AIA Group Ltd grew its stake in shares of CME Group by 17.8% during the first quarter. AIA Group Ltd now owns 16,645 shares of the financial services provider’s stock worth $4,416,000 after purchasing an additional 2,510 shares during the period. Finally, Insight Inv LLC acquired a new stake in shares of CME Group during the first quarter worth $2,712,000. 87.75% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at CME Group

In other news, General Counsel Jonathan L. Marcus sold 392 shares of the company’s stock in a transaction dated Thursday, September 18th. The stock was sold at an average price of $262.00, for a total transaction of $102,704.00. Following the completion of the transaction, the general counsel directly owned 7,851 shares of the company’s stock, valued at $2,056,962. This represents a 4.76% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Timothy Francis Mccourt sold 379 shares of the company’s stock in a transaction dated Tuesday, September 16th. The stock was sold at an average price of $259.83, for a total value of $98,475.57. Following the transaction, the insider directly owned 9,508 shares of the company’s stock, valued at $2,470,463.64. This represents a 3.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 13,043 shares of company stock valued at $3,527,956 over the last three months. 0.30% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the company. TD Cowen lifted their price objective on CME Group from $281.00 to $288.00 and gave the stock a “hold” rating in a research note on Wednesday, October 8th. Raymond James Financial decreased their target price on CME Group from $309.00 to $307.00 and set an “outperform” rating for the company in a research note on Monday, October 13th. Citigroup raised CME Group from a “neutral” rating to a “buy” rating and boosted their target price for the company from $275.00 to $300.00 in a research note on Thursday, September 25th. Morgan Stanley boosted their target price on CME Group from $303.00 to $312.00 and gave the company an “overweight” rating in a research note on Wednesday, October 1st. Finally, Wall Street Zen cut CME Group from a “hold” rating to a “sell” rating in a research note on Sunday, July 13th. Seven research analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, CME Group presently has an average rating of “Hold” and a consensus price target of $283.71.

CME Group Stock Down 0.3%

NASDAQ:CME opened at $267.81 on Thursday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The stock has a market cap of $96.51 billion, a price-to-earnings ratio of 25.93, a PEG ratio of 6.18 and a beta of 0.41. The stock has a 50-day moving average price of $266.67 and a two-hundred day moving average price of $271.45. CME Group Inc. has a 1 year low of $213.94 and a 1 year high of $290.79.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share for the quarter, topping the consensus estimate of $2.63 by $0.05. The company had revenue of $1.54 billion during the quarter, compared to analysts’ expectations of $1.56 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%.CME Group’s revenue for the quarter was down 3.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.68 earnings per share. As a group, equities analysts expect that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were given a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. The ex-dividend date of this dividend was Tuesday, September 9th. CME Group’s dividend payout ratio is currently 48.40%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.